Cargando…
The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013
OBJECTIVES: Few studies have assessed the long-term medical costs and incidence of obesity and overweight in Asia. We evaluated the impact of body mass index (BMI) on medical expenditures and disease incidence and prevalence over more than 10 years in South Korea. METHODS: Using 2002–2013 data from...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944944/ https://www.ncbi.nlm.nih.gov/pubmed/29746509 http://dx.doi.org/10.1371/journal.pone.0197057 |
_version_ | 1783321910071787520 |
---|---|
author | Song, Hyun Jin Hwang, Jinseub Pi, Seonmi Ahn, Sena Heo, Yoonseok Park, Susan Kwon, Jin-Won |
author_facet | Song, Hyun Jin Hwang, Jinseub Pi, Seonmi Ahn, Sena Heo, Yoonseok Park, Susan Kwon, Jin-Won |
author_sort | Song, Hyun Jin |
collection | PubMed |
description | OBJECTIVES: Few studies have assessed the long-term medical costs and incidence of obesity and overweight in Asia. We evaluated the impact of body mass index (BMI) on medical expenditures and disease incidence and prevalence over more than 10 years in South Korea. METHODS: Using 2002–2013 data from the Korean National Claims Database, we analysed two population sets (initial BMI in 2002–2003; consistent BMI in 2002–2003 and 2012–2013). Obesity was defined by Asian BMI criteria. Incremental medical expenditures or Charlson Comorbidity Index (CCI) ratios for obese compared to normal weight individuals were calculated. Medical expenditure over 11 years was estimated by BMI using a generalised linear model. Individual obesity-related disease incidence was determined and adjusted hazard ratios were calculated. RESULTS: Data for 496,469 and 214,477 individuals were included in the entire and consistent BMI level populations, respectively. Average CCI score change in normal weight and the obesity III (BMI 35–59.99 kg/m(2)) group over 11 years were 0.94 and 1.56, respectively in the entire population, and incremental ratio in the obesity III group was 66.0% compared to the normal weight group. In consistent BMI level population, incremental ratio (92.1%) for obesity III was higher than entire population. Medical costs in the obesity III groups versus the normal weight group in the entire and consistent BMI level populations increased by 38.4% and 77.1%, respectively. Over 11 years, individuals with BMI ≥30 kg/m(2) in the entire and consistent BMI level populations had post-adjustment medical expenditures of 1.13–1.20 and 1.21–1.40 times the normal weight group, respectively. Incidence rate and adjusted hazard ratio of obesity-related disease increased in the obesity groups compared to the normal weight group. CONCLUSIONS: Our findings emphasize the importance of the effective and sustainable obesity management strategies, considering the dramatic increase in obesity (BMI ≥30 kg/m(2)) in South Korea. |
format | Online Article Text |
id | pubmed-5944944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-59449442018-05-25 The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 Song, Hyun Jin Hwang, Jinseub Pi, Seonmi Ahn, Sena Heo, Yoonseok Park, Susan Kwon, Jin-Won PLoS One Research Article OBJECTIVES: Few studies have assessed the long-term medical costs and incidence of obesity and overweight in Asia. We evaluated the impact of body mass index (BMI) on medical expenditures and disease incidence and prevalence over more than 10 years in South Korea. METHODS: Using 2002–2013 data from the Korean National Claims Database, we analysed two population sets (initial BMI in 2002–2003; consistent BMI in 2002–2003 and 2012–2013). Obesity was defined by Asian BMI criteria. Incremental medical expenditures or Charlson Comorbidity Index (CCI) ratios for obese compared to normal weight individuals were calculated. Medical expenditure over 11 years was estimated by BMI using a generalised linear model. Individual obesity-related disease incidence was determined and adjusted hazard ratios were calculated. RESULTS: Data for 496,469 and 214,477 individuals were included in the entire and consistent BMI level populations, respectively. Average CCI score change in normal weight and the obesity III (BMI 35–59.99 kg/m(2)) group over 11 years were 0.94 and 1.56, respectively in the entire population, and incremental ratio in the obesity III group was 66.0% compared to the normal weight group. In consistent BMI level population, incremental ratio (92.1%) for obesity III was higher than entire population. Medical costs in the obesity III groups versus the normal weight group in the entire and consistent BMI level populations increased by 38.4% and 77.1%, respectively. Over 11 years, individuals with BMI ≥30 kg/m(2) in the entire and consistent BMI level populations had post-adjustment medical expenditures of 1.13–1.20 and 1.21–1.40 times the normal weight group, respectively. Incidence rate and adjusted hazard ratio of obesity-related disease increased in the obesity groups compared to the normal weight group. CONCLUSIONS: Our findings emphasize the importance of the effective and sustainable obesity management strategies, considering the dramatic increase in obesity (BMI ≥30 kg/m(2)) in South Korea. Public Library of Science 2018-05-10 /pmc/articles/PMC5944944/ /pubmed/29746509 http://dx.doi.org/10.1371/journal.pone.0197057 Text en © 2018 Song et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Song, Hyun Jin Hwang, Jinseub Pi, Seonmi Ahn, Sena Heo, Yoonseok Park, Susan Kwon, Jin-Won The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 |
title | The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 |
title_full | The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 |
title_fullStr | The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 |
title_full_unstemmed | The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 |
title_short | The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 |
title_sort | impact of obesity and overweight on medical expenditures and disease incidence in korea from 2002 to 2013 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944944/ https://www.ncbi.nlm.nih.gov/pubmed/29746509 http://dx.doi.org/10.1371/journal.pone.0197057 |
work_keys_str_mv | AT songhyunjin theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT hwangjinseub theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT piseonmi theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT ahnsena theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT heoyoonseok theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT parksusan theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT kwonjinwon theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT songhyunjin impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT hwangjinseub impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT piseonmi impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT ahnsena impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT heoyoonseok impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT parksusan impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 AT kwonjinwon impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013 |